Back to top

Globus Medical initiated with a Neutral at UBS

UBS initiated coverage of Globus Medical (GMED) with a Neutral rating and $82 price target The firm sees modest spine market growth ahead, with sur...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Globus Medical, Inc. (GMED)